|
08 Apr 2020 |
Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May
|
|
08 Apr 2020 |
EpiVax Partners with GAIA Vaccine Foundation to Make COVID-19 Vaccine License Free to Developing Countries
|
|
06 Apr 2020 |
GSK and Vir Biotechnology enter collaboration to find coronavirus solutions
|
|
06 Apr 2020 |
Akers Biosciences and Premas Biotech Announce Progress in its Vaccine Development for Covid-19
|
|
06 Apr 2020 |
OncoSec Collaborates with Providence Cancer Institute to Conduct First-in-Human Trial of OncoSec's CORVax12, an Investigational Vaccine to Prevent COVID-19, Combining an Enhanced "Spike" DNA Sequence and TAVO™
|
|
06 Apr 2020 |
INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today
|
|
04 Apr 2020 |
Update on GSK actions to support the global response to COVID-19
|
|
03 Apr 2020 |
Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Develop Potential COVID-19 Vaccine
|
|
02 Apr 2020 |
Applied DNA and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate
|
|
01 Apr 2020 |
Vaxart Provides Update on its Oral COVID-19 Vaccine Program
|
|
01 Apr 2020 |
VBI Vaccines Announces Collaboration with the National Research Council of Canada to Develop Pan-Coronavirus Vaccine Candidate Targeting COVID-19, SARS, and MERS
|
|
31 Mar 2020 |
Cobra Biologics and the Karolinska Institutet collaborate to develop COVID-19 vaccine
|
|
30 Mar 2020 |
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
|
|
27 Mar 2020 |
Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19
|
|
26 Mar 2020 |
INOVIO Reports Positive Interim Phase 2 VGX-3100 Results In Patients with HPV-associated Anal Dysplasia
|
|
26 Mar 2020 |
Sorrento Launches Novel I-Cell™ COVID-19 Cellular Vaccine Program
|
|
26 Mar 2020 |
Dynavax and CEPI Announce Collaboration to Support Global Effort to Develop a Vaccine for Coronavirus (COVID-19)
|
|
26 Mar 2020 |
SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
|
|
25 Mar 2020 |
Sartorius Supports the Development of the First Vaccine Candidate Against the Novel Coronavirus to Enter Clinical Trials
|
|
25 Mar 2020 |
Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech
|
|
24 Mar 2020 |
eTheRNA Launches an International Consortium and Starts Development of Cross-strain Protective CoV-2 mRNA Vaccine for High Risk Populations
|
|
24 Mar 2020 |
Ufovax successfully extended its Nanoparticle vaccine technology to SARS-CoV-2
|
|
24 Mar 2020 |
Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant
|
|
24 Mar 2020 |
Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial
|
|
23 Mar 2020 |
Hoth Therapeutics Announces Agreement to Joint Development for a Self-Assembling Vaccine (SAV) for the Potential Prevention of the Coronavirus (COVID-19)
|
